author-photo

Virginia Davenport

Columbia University

19

Papers

486

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Pediatric diffuse large B‐cell lymphoma demonstrates a high proliferation index, frequent c‐Myc protein expression, and a high incidence of germinal center subtype: Report of the French–American–British (FAB) international study group

2008 Pediatric Blood & Cancer
Show All
- Source
- Cite
- Save
Citations (62)
Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas: a children's oncology group report.

2007 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (18)
The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes

2007 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (42)
185: Feasibility of autologous stem cell transplant followed by reduced intensity allogeneic stem cell transplantation for high risk neuroblastoma: A single institution pilot study

2007 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (8)
Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: The Children's Cancer Group (CCG) experience

2005 Pediatric Blood & Cancer
Show All
- Source
- Cite
- Save
Citations (84)
Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study*

2005 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (28)
A comparison of rhTPO and rhIL-11 following ifosfamide (I), carboplatin (C) and etoposide (E) (ICE) in pediatric patients with recurrent solid tumors or lymphoma

2004 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
832 Ifosfamide, carboplatin, etoposide induces a 50% overall response rate and 1 year overall survival rate in patients with recurrent/refractory soft tissue and bone sarcoma: Embryonal rhabdomyosarcoma histology and complete response to ICE are independent factors significantly associated with improved survival

2003 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (0)
Feasibility study of IL-11 and granulocyte colony-stimulating factor after myelosuppressive chemotherapy to mobilize peripheral blood stem cells from heavily pretreated patients.

2001 Journal of Pediatric Hematology Oncology
Show All
- Source
- Cite
- Save
Citations (18)
A Phase I Clinical, Pharmacological, and Biological Trial of Interleukin 6 Plus Granulocyte-Colony Stimulating Factor after Ifosfamide, Carboplatin, and Etoposide in Children with Recurrent/Refractory Solid Tumors: Enhanced Hematological Responses but a High Incidence of Grade III/IV Constitutional Toxicities

2001 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (16)